Clinical Trial Update: Valproic AcId for Traumatic BRAin INjury Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describes a Phase 2/Phase 3 study of valproic acid for moderate to severe traumatic brain injury; the study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Northwestern University | Conditions: Moderate Traumatic Brain Injury (TBI), Severe Traumatic Brain Injury | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING